Learn More
Medchemexpress LLC 2-(3,5-difluoro-4-hydroxyanilino)-5,7-dimethyl-8-(3-methylbutyl)-7H-pteridin-6-one | 501437-28-1 | MFCD11223662 | 99.4% | 391.42 g·mol⁻¹ | C19H23F2N5O2 | 25 MG

Supplier: Medchemexpress LLC HY1051025MG
BI-D1870 is an ATP-competitive, cell-permeable, brain-penetrant inhibitor of p90 ribosomal S6 kinases (RSK1-4) with low-nanomolar potency. It is used as a research tool in biochemical kinase assays and cell-based studies to probe RSK-dependent signaling pathways.
- Low-nanomolar potency against RSK1-4 (reported IC50s ~31-15 nM).
- ATP-competitive mechanism of inhibition, suitable for biochemical kinase assays.
- Cell permeable and reported to penetrate the brain for in vivo applications.
- High purity, typically around 99.4% for research-grade material.
- Available in small pack sizes for laboratory use, e.g., 25 MG.
- Well-characterized identifiers: CAS 501437-28-1, MFCD11223662.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.